NCT01514136

Brief Summary

Coloplast A/S has developed a new ostomy device in 8 versions. The primary objective of this investigation is to assess and compare the degree of leakage when using the 8 different devices. The secondary objective is to investigate several performance and safety parameters of the various devices. The aim of the primary and secondary objectives is to acquire more knowledge about the performance of the newly developed device and inspiration for their further development, if needed. Given that the investigation is exploratory, pass/fail criteria are not relevant. The investigation result will provide knowledge useful for continued decision-making/device development. The investigation is designed as a non-blinded, controlled, exploratory investigation that includes a total of 30-40 Danish ileostomy users. Each subject will test a maximum of 4 convex devices in two rounds of each 4 weeks. Each device will be tested for 7 (± 2) days.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
32

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Sep 2011

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 2011

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2011

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2012

Completed
9 days until next milestone

First Submitted

Initial submission to the registry

January 10, 2012

Completed
10 days until next milestone

First Posted

Study publicly available on registry

January 20, 2012

Completed
3 years until next milestone

Results Posted

Study results publicly available

January 29, 2015

Completed
Last Updated

March 11, 2015

Status Verified

February 1, 2015

Enrollment Period

3 months

First QC Date

January 10, 2012

Results QC Date

January 19, 2015

Last Update Submit

February 20, 2015

Conditions

Outcome Measures

Primary Outcomes (1)

  • Degree of Leakage

    The degree of leakage under the baseplate was measured on a 24-point scale where 0 point was the best possible outcome with no leakage under the baseplate and 24-point was the worst possible outcome with leakage under the whole plate. The scale was developed by Coloplast A/S

    One week

Study Arms (1)

One arm

EXPERIMENTAL

The arm consists of two periods: in period one, products are tested in the order A, B, C, D, and in period two, products are tested in the order A\*, B\*, C\*, D\*.

Device: Ostomy appliance: convex 1-piece drainable

Interventions

8 variations of an ostomy devices are tested

One arm

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Be at least 18 years old
  • Have signed the declaration of informed consent
  • Have an ileostomy in a concave area
  • Have had an ileostomy for at least three months
  • Have used convex plates (for convex users) or flat plates (for flat plate users) for the last month
  • Be users of 1-piece or 2-piece open ostomy devices
  • Have an ileostomy with a diameter of less than 33 mm

You may not qualify if:

  • Are pregnant or breast-feeding
  • Have a double-loop ileostomy
  • Have known hypersensitivity or allergy to the devices' component ingredients
  • Are receiving/have received radiation treatment and/or chemotherapy within the last 3 months.
  • Are receiving/have received local peristomal or systemic steroid treatment within the last month
  • Suffer from peristomal skin problems that preclude participation in the investigation (assessed by the investigation nurse)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Coloplast A/S

Humlebæk, Denmark, 3050, Denmark

Location

Limitations and Caveats

This was an exploratory investigation where the participating subjects had to test 8 different test products. A small number of subjects were analysed from two different populations (convex product/flat product users).

Results Point of Contact

Title
Birte Petersen Jakobsen, MD
Organization
Coloplast A/S

Study Officials

  • Birte P Jakobsen, MD

    Coloplast A/S

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Intervention Model
SINGLE GROUP
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 10, 2012

First Posted

January 20, 2012

Study Start

September 1, 2011

Primary Completion

December 1, 2011

Study Completion

January 1, 2012

Last Updated

March 11, 2015

Results First Posted

January 29, 2015

Record last verified: 2015-02

Locations